Skip to content
★ Sign in to follow
AG
Total declarations
44
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (36 ops.)
€1.8M

Latest filing published 23 Jun 2008 for BIOGEN INC..

Insider track record

Disclosed buys
0
Disclosed sells
36
Signal history

No signal scores available.

Alan Glassberg: trading record in brief

Alan Glassberg is a declared insider of Biogen Inc., with filings sourced from SEC (Form 4). Between 26 May 2004 and 19 June 2008, the trades on record add up to 44 filings.

On the market, this insider has only sold: 36 sales, €1.8M in total. Besides market trades, the filings include 2 share grants and 6 option exercises. Since January 2008: no purchases and 28 sales on the market.

The record was last updated on 23 June 2008 with a share grant in Biogen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Alan Glassberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations44 total
  • ◆
    DirectorExecutivesBiogen Inc.
    0SEC
    2,050 shares0Common StockSEC:0001209191-08-038382:0
  • ◇
    DirectorExecutivesBiogen Inc.
    310,800 USD0SEC
    10,000 shares@ US$31.08Common StockSEC:0001209191-08-026711:0
  • ▼
    DirectorExecutivesBiogen Inc.
    18,384 USD0SEC
    300 shares@ US$61.28Common StockSEC:0001209191-08-026711:1
  • ▼
    DirectorExecutivesBiogen Inc.
    12,264 USD0SEC
    200 shares@ US$61.32Common StockSEC:0001209191-08-026711:2
  • ▼
    DirectorExecutivesBiogen Inc.
    6,135 USD0SEC
    100 shares@ US$61.35Common StockSEC:0001209191-08-026711:3
  • ▼
    DirectorExecutivesBiogen Inc.
    18,417 USD0SEC
    300 shares@ US$61.39Common StockSEC:0001209191-08-026711:4
  • ▼
    DirectorExecutivesBiogen Inc.
    12,280 USD0SEC
    200 shares@ US$61.40Common StockSEC:0001209191-08-026711:5
  • ▼
    DirectorExecutivesBiogen Inc.
    12,290 USD0SEC
    200 shares@ US$61.45Common StockSEC:0001209191-08-026711:6
  • ▼
    DirectorExecutivesBiogen Inc.
    12,294 USD0SEC
    200 shares@ US$61.47Common StockSEC:0001209191-08-026711:7
  • ▼
    DirectorExecutivesBiogen Inc.
    6,148 USD0SEC
    100 shares@ US$61.48Common StockSEC:0001209191-08-026711:8
  • ▼
    DirectorExecutivesBiogen Inc.
    18,447 USD0SEC
    300 shares@ US$61.49Common StockSEC:0001209191-08-026711:9
  • ▼
    DirectorExecutivesBiogen Inc.
    36,900 USD0SEC
    600 shares@ US$61.50Common StockSEC:0001209191-08-026711:10
  • ▼
    DirectorExecutivesBiogen Inc.
    24,604 USD0SEC
    400 shares@ US$61.51Common StockSEC:0001209191-08-026711:11
  • ▼
    DirectorExecutivesBiogen Inc.
    49,256 USD0SEC
    800 shares@ US$61.57Common StockSEC:0001209191-08-026711:12
  • ▼
    DirectorExecutivesBiogen Inc.
    6,164 USD0SEC
    100 shares@ US$61.64Common StockSEC:0001209191-08-026711:13
  • ▼
    DirectorExecutivesBiogen Inc.
    43,162 USD0SEC
    700 shares@ US$61.66Common StockSEC:0001209191-08-026711:14
  • ▼
    DirectorExecutivesBiogen Inc.
    37,002 USD0SEC
    600 shares@ US$61.67Common StockSEC:0001209191-08-026711:15
  • ▼
    DirectorExecutivesBiogen Inc.
    12,336 USD0SEC
    200 shares@ US$61.68Common StockSEC:0001209191-08-026711:16
  • ▼
    DirectorExecutivesBiogen Inc.
    12,338 USD0SEC
    200 shares@ US$61.69Common StockSEC:0001209191-08-026711:17
  • ▼
    DirectorExecutivesBiogen Inc.
    18,510 USD0SEC
    300 shares@ US$61.70Common StockSEC:0001209191-08-026711:18
  • ▼
    DirectorExecutivesBiogen Inc.
    86,422 USD0SEC
    1,400 shares@ US$61.73Common StockSEC:0001209191-08-026711:19
  • ▼
    DirectorExecutivesBiogen Inc.
    24,696 USD0SEC
    400 shares@ US$61.74Common StockSEC:0001209191-08-026711:20
  • ▼
    DirectorExecutivesBiogen Inc.
    18,528 USD0SEC
    300 shares@ US$61.76Common StockSEC:0001209191-08-026711:21
  • ▼
    DirectorExecutivesBiogen Inc.
    24,708 USD0SEC
    400 shares@ US$61.77Common StockSEC:0001209191-08-026711:22
  • ▼
    DirectorExecutivesBiogen Inc.
    12,356 USD0SEC
    200 shares@ US$61.78Common StockSEC:0001209191-08-026711:23

25 of 44 declarations